NRIX (nurixtx.com) Enterprise Value-to-Revenue Coefficient

Official company branding of Nurix Therapeutics Inc (NRIX)

Reliable reagent delivery to laboratories ensures the stability of Nurix Therapeutics developments. This EV/Sales market multiple chart on GURU.Markets demonstrates investor consensus, where the 716.40 metric determines this level. Synergy with pharma behemoths accelerates clinical trials, while the unique protein degradation platform strengthens the company's moat and the value of its intellectual property.

nurixtx.com (NRIX): EV/Sales Multiple from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Nurix Therapeutics, Inc. (NRIX)

- business market valuation indicators:
- cash balance and cash flow data:
Fundamental company valuation:Nurix Therapeutics NRIX
Product sample of nurixtx.com

This metric determines the market value of a business, accounting for net debt relative to the volume of generated sales. By analyzing the EV/Sales history, an investor assesses the efficiency of revenue capitalization. The calculation combines the value of equity and liabilities, excluding cash to ensure an objective valuation. For Nurix Therapeutics (NRIX), this reflects the market value of innovations in the field of protein degradation. High values here are justified by the potential for strategic partnerships in oncology.